Follow us
EN
EN

One of the main goals of Life4me+ — is to prevent new cases of HIV and other STIs, hepatitis C and tuberculosis.

The app helps to establish anonym communication between physicians and HIV-positive people. It allows you to conveniently organize your medication intake timetable and set concealed and personalized reminders.

All news

Archive

✕
21 March 2017
5987
Tuberculosis deaths fall in Europe, ECDC reports

Tuberculosis deaths fall in Europe, ECDC reports

The number of people developing and dying from tuberculosis (TB) is decreasing in Europe, but among the most vulnerable - including prisoners, migrants, and people living with HIV - there have been disturbing increases, the Reuters reported on Monday. Figures from the European ...
21 March 2017
6214
Is Dolutegravir Monotherapy Effective in Treating HIV?

Is Dolutegravir Monotherapy Effective in Treating HIV?

The authors of the multicenter study performed in the Netherlands hypothesised that Dolutegravir (DTG) monotherapy (DTG 50 mg by mouth daily) was non-inferior to ART in sustaining virologic suppression. The results of this study was reported at CROI 2017. Although dolutegravir ...
20 March 2017
5570
Researchers Map Pathways To Protective Antibodies For An HIV Vaccine

Researchers Map Pathways To Protective Antibodies For An HIV Vaccine

A Duke Health-led research team has described both the pathway of HIV protective antibody development and a synthetic HIV outer envelope mimic that has the potential to induce the antibodies with vaccination. "A goal for an HIV-1 vaccine is to induce broadly neutralising ...
20 March 2017
5834
Insulin May Help Restore Neurocognitive Functions in HIV Patients

Insulin May Help Restore Neurocognitive Functions in HIV Patients

Delivering insulin within the nasal cavity helped prevent neuroinflammation, neuronal injury, and restored neurobehavioral function, a study in HIV mouse models showed. HIV-associated neurocognitive disorders (HAND) describe a spectrum disorder of neurocognitive dysfunctions ...
20 March 2017
5676
Lurking HIV Detected in a Major Biomarker Discovery

Lurking HIV Detected in a Major Biomarker Discovery

A unique protein that gives away the presence of inactive HIV in the body has been discovered by a team scientists from the University of Montpellier in France. According to the article in Nature, researchers achieved a significant milestone in HIV research by identifying ...
16 March 2017
5729
Trump Proposes To Cut NIH Funding By 19 Percent

Trump Proposes To Cut NIH Funding By 19 Percent

The NIH would absorb $5.8 billion cut under President Trump’s first budget proposal. This is about 19 percent of its current $30.3 billion budget. The agency funds research into a broad array of diseases and conditions, including HIV, cancer, developmental disorders, heart ...
15 March 2017
6172
“Art Hearts Fashion” Raise HIV/AIDS Awareness During LA Fashion Week

“Art Hearts Fashion” Raise HIV/AIDS Awareness During LA Fashion Week

AIDS Healthcare Foundation (AHF) will partner with Art Hearts Fashion to raise awareness about HIV/AIDS as part of the Fall/Winter 2017 LA Fashion Week collection of shows. The aim of this action is to promote sexual health through HIV/STD testing, treatment and condom usage. Founded ...
15 March 2017
5286
Early Antibody Therapy Has "Taught" The Macaques' Immune System To Fight HIV

Early Antibody Therapy Has "Taught" The Macaques' Immune System To Fight HIV

A new approach to the HIV therapy on the monkey model (SHIV) proposed recently in the Nature journal by a group of microbiologists from the U. S. and Germany. Michele Nussentswijg from the Rockefeller University in New York (USA), said, the use of two novel antibodies, ...
15 March 2017
7318
GeoVax And American Gene Technologies Announced Collaboration For HIV Functional Cure

GeoVax And American Gene Technologies Announced Collaboration For HIV Functional Cure

GeoVax Labs announced its collaboration with American Gene Technologies International (AGT) for the administration of Phase 1 clinical trial studying the companies’ consolidated technologies as a functional cure for HIV infection. AGT plans to conduct a Phase 1 clinical ...
15 March 2017
5757
Novel Intervention Strategies To Increase Cost-Effectiveness Of HIV Treatment Adherence

Novel Intervention Strategies To Increase Cost-Effectiveness Of HIV Treatment Adherence

Recently developed Adherence Improving self-Management Strategy (AIMS) produced significant effects on viral load and was cost-effective in a high-resource setting, compared with treatment as usual. Health Psychologists and clinicians from Aberdeen and the Netherlands used ...
We use cookies on this site to enhance your experience.
By clicking any button on this website you are giving your consent for us to set cookies.